Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus

Julia Moesslacher, Verena Battisti, Leen Delang, Johan Neyts, Rana Abdelnabi, Gerhard Pürstinger, Ernst Urban, Thierry LangerACS 2020 · DOI

Abstract

The chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus, and it is the causative agent of chikungunya fever (CHIKF). Although it has re-emerged as an epidemic threat, so far there are neither vaccines nor pharmacotherapy available to prevent or treat an infection. Herein, we describe the synthesis and structure-activity relationship studies of a class of novel small molecule inhibitors against CHIKV and the discovery of a new potent inhibitor (compound <b>6a</b>). The starting point of the optimization process was <i>N</i>-ethyl-6-methyl-2-(4-(4-fluorophenylsulfonyl)piperazine-1-yl)pyrimidine-4-amine (<b>1</b>) with an EC<sub>50</sub> of 8.68 μM, a CC<sub>50</sub> of 122 μM, and therefore a resulting selectivity index (SI) of 14.2. The optimized compound <b>6a</b>, however, displays a much lower micromolar antiviral activity (EC<sub>50</sub> value of 3.95 μM), considerably better cytotoxic liability (CC<sub>50</sub> value of 260 μM) and consequently an improved SI of greater than 61. Therefore, we report the identification of a promising novel compound class that has the potential for further development of antiviral drugs against the CHIKV.
BibTeX
@inproceedings{moesslacher2020identification,
  author = {Julia Moesslacher and Verena Battisti and Leen Delang and Johan Neyts and Rana Abdelnabi and Gerhard Pürstinger and Ernst Urban and Thierry Langer},
  title = {{Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus}},
  booktitle = {ACS},
  year = {2020},
  doi = {10.1021/acsmedchemlett.9b00662},
}

Loading related content...

Figure